2-166012276-C-G
Variant summary
Our verdict is Likely pathogenic. The variant received 9 ACMG points: 9P and 0B. PM1PM2PM5PP2PP3_Moderate
The NM_001165963.4(SCN1A):c.3712G>C(p.Glu1238Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000138 in 1,454,194 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E1238K) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001165963.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 9 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SCN1A | NM_001165963.4 | c.3712G>C | p.Glu1238Gln | missense_variant | Exon 22 of 29 | ENST00000674923.1 | NP_001159435.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SCN1A | ENST00000674923.1 | c.3712G>C | p.Glu1238Gln | missense_variant | Exon 22 of 29 | NM_001165963.4 | ENSP00000501589.1 | |||
| SCN1A | ENST00000303395.9 | c.3712G>C | p.Glu1238Gln | missense_variant | Exon 21 of 28 | 5 | ENSP00000303540.4 | |||
| SCN1A | ENST00000375405.7 | c.3679G>C | p.Glu1227Gln | missense_variant | Exon 19 of 26 | 5 | ENSP00000364554.3 | |||
| SCN1A | ENST00000409050.2 | c.3628G>C | p.Glu1210Gln | missense_variant | Exon 21 of 28 | 5 | ENSP00000386312.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000406 AC: 1AN: 246472 AF XY: 0.00000750 show subpopulations
GnomAD4 exome AF: 0.00000138 AC: 2AN: 1454194Hom.: 0 Cov.: 29 AF XY: 0.00000276 AC XY: 2AN XY: 723564 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy Uncertain:1
This sequence change replaces glutamic acid with glutamine at codon 1238 of the SCN1A protein (p.Glu1238Gln). The glutamic acid residue is highly conserved and there is a small physicochemical difference between glutamic acid and glutamine. This variant is present in population databases (rs750364705, ExAC 0.01%) but has not been reported in the literature in individuals with a SCN1A-related disease. A different variant at this codon, c.3714A>C (p.Glu1238Asp), and two variants at the adjacent codon, c.3715G>T (p.D1239Y) and c.3716A>G (p.D1239G), have all been seen in individuals affected with epilepsy (PMID: 16713920, 17347258, 18930999), however the clinical significance of these variants is unknown. This variant is in the extracellular loop between segments 1 & 2 of the D3 domain in SCN1A, at a glutamic acid residue that is highly conserved across ion channel genes (PMID: 18804930, 22581653). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies. In summary, this is a rare missense change with uncertain impact on protein function. There is no indication that this variant causes disease, but the evidence is insufficient at this time to prove that conclusively. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at